Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | GALK1 | P51570 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717056 | 0.93 | MEN1 (0.48) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL27862666 | 0.91 | MEN1 (0.47) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL27865902 | 0.89 | ALDH1A1 (0.41) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL2051735 | 0.87 | MEN1 (0.48) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL28939189 | 0.85 | MEN1 (0.42) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL6228874 | 0.82 | MEN1 (0.41) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL712927 | 0.79 | MEN1 (0.48) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL2051093 | 0.77 | CA12 (0.41) | MEN1MAPTKMT2ANPC1RAB9A | |
| SCHEMBL27862656 | 0.77 | MEN1 (0.47) | MEN1LMNAMAPTHTTKMT2A | |
| SCHEMBL18426 | 0.75 | ALDH1A1 (0.44) | MEN1LMNAMAPTHTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3584075-B1 | LAMINATE | MITSUI CHEMICALS INC (JP) | 2024-06-05 | — | — | EP | disclosed |
| US-11964447-B2 | Laminate | MITSUI CHEMICALS, INC. (JP) | 2024-04-23 | — | — | US | disclosed |
| US-11905348-B2 | Ethylene/alpha-olefin/non-conjugated polyene copolymer, method for producing the same, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2024-02-20 | — | — | US | disclosed |
| EP-3584074-B1 | LAMINATE | MITSUI CHEMICALS INC (JP) | 2023-06-21 | — | — | EP | disclosed |
| EP-3424705-B1 | LAMINATE AND APPLICATION FOR SAME | MITSUI CHEMICALS INC (JP) | 2023-03-22 | — | — | EP | disclosed |
| CN-111868116-B | Ethylene-alpha-olefin-nonconjugated polyene copolymer, process for producing the same, and use thereof | 三井化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| CN-110312618-B | Laminated body | 三井化学株式会社 | 2021-09-07 | — | — | CN | disclosed |
| CN-110325360-B | Laminated body | 三井化学株式会社 | 2021-07-20 | — | — | CN | disclosed |
| US-10975223-B2 | Resin composition and use thereof | MITSUI CHEMICALS, INC. (JP) | 2021-04-13 | — | — | US | disclosed |
| EP-3770190-A1 | ETHYLENE/& X3B1;-OLEFIN/NON-CONJUGATED POLYENE COPOLYMER, PRODUCTION METHOD THEREFOR, AND USE | Mitsui Chemicals, Inc. (JP) | 2021-01-27 | — | — | EP | disclosed |
| US-7851569-B2 | Rare earth metal complex, polymerization catalyst, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20100261857-A1 | OLEFIN/(METH)ACRYLATE BLOCK COPOLYMER AND METHOD FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2189483-A1 | OLEFIN/(METH)ACRYLATE BLOCK COPOLYMER AND METHOD FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20100093957-A1 | METHOD FOR PRODUCING BUTENE-ETHYLENE COPOLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2123685-A1 | METHOD FOR PRODUCING BUTENE-ETHYLENE COPOLYMER | Sumitomo Chemical Company, Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-7615660-B2 | Production process of alkoxy-titanium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20090253875-A1 | RARE EARTH METAL COMPLEX, POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-10-08 | — | — | US | disclosed |
| EP-2045254-A1 | RARE EARTH METAL COMPLEX, CATALYST FOR POLYMERIZATION AND PROCESS FOR PRODUCING POLYMER | Sumitomo Chemical Company, Limited (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1845101-A1 | METHOD FOR PRODUCING ALKOXYTITANIUM COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2007-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | ABL1, H1-10, ALK | MEN1 2235/4885LMNA 3910/4885MAPT 4631/4885 |
| US-20090253875-A1 | RARE EARTH METAL COMPLEX, POLYMERIZATION CATALYST AND METHOD FOR PRODUCING POLYMER | RPS27L, LAS1L, AGL | MEN1 2288/4885LMNA 1206/4885MAPT 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.